Nasdaq:US$12.13 (-0.47) | HKEX:HK$18.98 (-0.42) | AIM:£1.92 (-0.08)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing